Drug Shortage Report for TARO-CARBAMAZEPINE
Report ID | 150620 |
Drug Identification Number | 02367394 |
Brand name | TARO-CARBAMAZEPINE |
Common or Proper name | CARBAMAZEPINE SUSPENSION |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | CARBAMAZEPINE |
Strength(s) | 100MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 450ML |
ATC code | N03AF |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-10-20 |
Estimated end date | 2022-04-29 |
Actual end date | 2022-05-16 |
Shortage status | Resolved |
Updated date | 2022-08-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-08-25 | French | Compare |
v7 | 2022-08-25 | English | Compare |
v6 | 2022-04-12 | French | Compare |
v5 | 2022-04-12 | English | Compare |
v4 | 2022-01-06 | French | Compare |
v3 | 2022-01-06 | English | Compare |
v2 | 2021-12-07 | French | Compare |
v1 | 2021-12-07 | English | Compare |
Showing 1 to 8 of 8